Secondary nucleation is suppressed in an air-lift crystallizer at levels of supersaturation where in a stirred crystallizer a clear contribution of secondary nucleation is visible. A comparison of batch crystallization of l -ascorbic acid in an air-lift crystallizer and in a stirred crystallizer is presented. The results demonstrate that at low supersaturation, secondary nucleation can be suppressed in both the air-lift crystallizer and the stirred crystallizer. At higher supersaturation, nucleation starts to dominate in the air-lift crystallizer. At an intermediate level of supersaturation, a clear contribution of secondary nucleation in the final product obtained from the stirred crystallizer is visible. However, experiments with similar conditions in the air-lift crystallizer show a significantly smaller contribution of secondary nucleation. The observed enlargement of the operating window in terms of supersaturation where secondary nucleation is suppressed in an air-lift crystallizer may have important practical consequences. Air-lift crystallizers can potentially operate with a higher crystal growth rate and the operating window for design and automated control can be extended.
No takes yet. Share an insight, caveat, or question.
Lakerveld et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: